Nippon India MF and Theleme India Master Fund Increase Stake in Sudarshan Chemical; ADIA Exits M & B Engineering
Back to News
Market2h agoPositiveMedium ImpactShort Term

Nippon India MF and Theleme India Master Fund Increase Stake in Sudarshan Chemical; ADIA Exits M & B Engineering

Detailed Analysis

Sudarshan Chemical Industries Sees Sharp Rise in Share Price Following Equity Stake Acquisition

On April 16, Nippon India Asset Management and Theleme India Master Fund acquired an additional 2.26 percent equity stake in Sudarshan Chemical Industries, a leading provider of pigments and color solutions, through open market transactions.

The deal has seemingly had a positive impact on Sudarshan Chemical shares, which soared by 7.74 percent to Rs 878.6 on the National Stock Exchange, forming a long bullish candle on the daily charts after breaking out of more than a month of consolidation.

Nippon India Mutual Fund Acquires 1.76 Percent Stake in Sudarshan Chemical

Nippon India Mutual Fund acquired 13.82 lakh shares in the company for Rs 111.95 crore, acquiring a 1.76 percent stake in Sudarshan Chemical. Theleme India Master Fund also picked up 4 lakh shares for Rs 32.4 crore, securing a 0.5 percent stake in the company. Their buying price was Rs 810 per share.

Promoters Offload 3 Percent Stake in Sudarshan Chemical

In a separate development, the promoters of Sudarshan Chemical, Rahul Pradeep Rathi Pradeep Ramwilas Rathi, and Anuj Narayandas Rathi, offloaded 3 percent stake in the company for Rs 191.09 crore. Rahul Pradeep Rathi sold 7.86 lakh shares in the company at Rs 810.73 per share, Pradeep Ramwilas Rathi sold the same number of shares at Rs 810.05 per share, and Anuj Narayandas Rathi sold the same number of shares at Rs 810 per share.

As of December 2025, the promoters held 3.85 percent, 4.36 percent, and 6.93 percent shares in Sudarshan Chemical, respectively.

Zee Entertainment Enterprises Falls 3.05 Percent Following Stake Sale

Zee Entertainment Enterprises was also in focus, falling 3.05 percent to Rs 80.2, possibly due to a stake sale by Vanguard. Vanguard Group-managed Vanguard International Value Fund sold 49.58 lakh shares in the company at Rs 80.36 per share, valued at Rs 39.84 crore. Vanguard Group through three funds held 5.01 percent stake in Zee as of December 2025.

| Company | Stake Sold | Price per Share | Value (in Crore) | | --- | --- | --- | --- | | Zee Entertainment Enterprises | 0.51 percent | Rs 80.36 | Rs 39.84 |

M & B Engineering Sees Brisk Action

The brisk action was also seen in M & B Engineering, the turnkey PEB & roofing solutions provider, which rose 1.74 percent to Rs 327. Abu Dhabi Investment Authority exited M & B Engineering by selling entire 12.91 lakh shares at Rs 324.5 per share, amounting to Rs 41.91 crore. However, 360 ONE Asset Management was the buyer for most of those shares, picking up 12.66 lakh shares for Rs 41.09 crore.

HCP Investments Pares Stake in Ind-Swift Laboratories

HCP Investments pared 1.12 percent stake in Ind-Swift Laboratories on Thursday, selling 8.65 percent shares held as of February 24, 2026. The foreign investors sold 4.77 lakh shares in Ind-Swift at Rs 143.58 per share, valued at Rs 6.86 crore, and 5 lakh shares at Rs 137.95 per share, amounting to Rs 6.9 crore.

Despite the stake sale by HCP, Ind-Swift Labs shares gained 0.94 percent to close at Rs 145.41 on the National Stock Exchange.

Investor Takeaway

Investors should be aware of the increased stake in Sudarshan Chemical Industries by Nippon India India Asset Management and Theleme India Master Fund.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
help@iposcanner.ai.

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.